Welcome to our dedicated page for Tompkins Financl SEC filings (Ticker: TMP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking community-bank health often means digging through hundreds of pages on loan performance, deposit growth, and capital ratios. Tompkins Financial’s disclosures are no exception—and missing a single 8-K about credit quality can skew your view of its risk profile. Stock Titan’s AI decodes every Tompkins filing the moment it hits EDGAR, turning dense tables into plain-English insights.
Need the numbers fast? Our platform tags the exact pages that explain net interest margin in the latest Tompkins Financial quarterly earnings report 10-Q filing and highlights allowance-for-loan-loss trends across periods. Wondering if executives are signaling confidence? Receive real-time alerts on Tompkins Financial Form 4 insider transactions and review AI commentary on buying or selling patterns.
Typical questions—“How to read Tompkins Financial’s 10-K?� or “Where can I find Tompkins Financial proxy statement executive compensation details?”—are answered inline. We map each insight to its source form:
- 10-K & 10-Q: credit risk, segment revenue, liquidity�Tompkins Financial annual report 10-K simplified
- 8-K: dividend declarations or branch sales�Tompkins Financial 8-K material events explained
- DEF 14A: board pay and community impact metrics�Tompkins Financial proxy statement executive compensation
- Form 4: insider trades�Tompkins Financial insider trading Form 4 transactions
Every filing is paired with concise AI summaries, trend charts, and peer comparisons, so understanding Tompkins Financial SEC documents with AI becomes routine. Save hours, monitor Tompkins Financial earnings report filing analysis, and stay ahead with Tompkins Financial SEC filings explained simply.
On 24-25 July 2025 Interactive Strength Inc. (TRNR) secured an additional $3.0 million when an accredited investor exercised Class A incremental warrants. In return, the company issued senior secured convertible notes (“Class A Incremental Notes�) maturing 25 July 2028 and Class A Incremental Common Warrants covering 304,428 shares.
Key terms: Notes are convertible any time before maturity at $5.42 per share (subject to adjustment) based on 110 % of principal plus accrued amounts, with 4.99 %/9.99 % ownership caps. Warrants are exercisable at $12.46 per share through 25 July 2032 and include customary anti-dilution protections.
Stockholders previously authorised up to 10.24 million shares for note conversions and 684,647 shares for warrant exercises (post-split). The new funding bolsters liquidity but heightens dilution risk and leverage due to the secured note structure.
The Board set the 2025 Annual Meeting for 26 September 2025, named 29 July 2025 as the record date and fixed 5 August 2025 as the deadline for shareholder proposals and director nominations.
Tompkins Financial Corp. (TMP) has submitted its Form 13F covering holdings as of 30 June 2025. The filing classifies as a 13F Holdings Report, indicating that all positions under management are disclosed in this document. According to the summary page, the firm reported 725 individual equity positions with an aggregate market value of $1,087,857,017 (rounded to the nearest dollar). No other institutional managers are included in this report and no amendments or restatements were made. The document was signed by Lisa Donnelly, Trust Operations Manager, in Ithaca, NY on 10 July 2025.
The filing does not provide a detailed position list in the extract supplied, nor does it discuss performance, sector allocation, or recent trading activity; it simply certifies the accuracy of reported holdings and the manager’s authority to file. Investors may use the total portfolio value and position count as a high-level indicator of the scale of assets managed within Tompkins Financial’s trust and wealth management division.
On 03-Jul-2025, Tompkins Financial Corporation (TMP) director Patricia A. Johnson filed a Form 4 reporting the acquisition of 268 common shares at an average price of $65.6456 per share. The stock was taken in lieu of cash retainer fees under the company’s Second Amended and Restated Retainer Plan for Eligible Directors, rather than through an open-market purchase. Following the transaction, Johnson’s direct holdings rose to 5,863.245 shares. No derivative securities or additional transactions were disclosed.
Tompkins Financial Corporation (TMP) director Helen Eaton filed a Form 4 on 3 July 2025 disclosing the acquisition of 446.336 phantom stock units on 2 July 2025 at a reference value of $65.6456 per underlying common share. The award was made under the company’s Amended and Restated Retainer Plan for Eligible Directors and is held in a rabbi trust until future distribution events. Each phantom unit is economically equivalent to one share of common stock but carries no voting or investment power until settlement.
Following the transactions, Eaton’s deferred-compensation balance rose to 2,174.102 phantom units. Because the shares were issued as board compensation rather than purchased on the open market, the transaction generates no immediate cash outlay, no dilution, and only a modest increase in insider exposure. Given Tompkins Financial’s roughly 14�15 million shares outstanding, the size of this award is immaterial from a valuation or control standpoint, though it does incrementally align director incentives with shareholder interests.
First Trust Portfolios L.P., First Trust Advisors L.P. and their parent, The Charger Corporation, jointly filed Amendment No. 31 to Schedule 13G for FT Vest U.S. Equity Deep Buffer ETF � May (CUSIP 33740F730) as of 30 June 2025. The filing discloses beneficial ownership of 2,547,803 shares, representing 38.31 % of the ETF’s outstanding units. All ownership is reported as shared; the group states it has no sole voting or dispositive power over the shares. The units are primarily held in unit investment trusts (UITs) sponsored by First Trust Portfolios, with oversight by First Trust Advisors. Voting rights are exercised by the UIT trustee to mirror broader shareholder voting patterns, and the filers expressly disclaim beneficial ownership beyond their administrative role. The Schedule was filed pursuant to Rule 13d-1(b), indicating passive intent and ordinary-course acquisition. Certifications affirm that the securities are not held to influence control of the issuer. James M. Dykas, CFO, signed on behalf of all three entities on 7 July 2025.
- Stake size: 2.55 million shares (38.31 %).
- Filing entities: First Trust Portfolios L.P. (broker-dealer), First Trust Advisors L.P. (investment adviser), The Charger Corporation (holding company).
- Voting/Disposition: 0 sole; 2.55 million shared.
- Purpose: Passive ownership via UITs; no intent to influence control.
Radware Ltd. (RDWR) has filed a Form 144 indicating the potential sale of 2,355 ordinary shares through broker Oppenheimer & Co. at an aggregate market value of $69,896.40. The proposed sales window opens on 03 July 2025 and the shares will trade on NASDAQ. The notice states that the seller acquired the stock via an Employee Stock Option Plan (605 shares) and two separate Restricted Stock Unit grants (total 5,000 shares) dated 2019-2020. With approximately 42.55 million shares outstanding, the filing represents well under 0.01% of total equity and does not change the public float. No prior sales were reported in the past three months, and the filer attests to possessing no undisclosed material adverse information.
Core Scientific, Inc. (Nasdaq: CORZ) filed an Item 7.01 Form 8-K disclosing that it has entered into an Agreement and Plan of Merger whereby CoreWeave, Inc. will acquire Core Scientific in an all-stock transaction dated 7 July 2025. The joint press release (Ex. 99.1) is furnished, not filed, meaning it is exempt from Exchange Act Section 18 liability and will not be incorporated into other SEC filings unless expressly referenced.
The filing contains no financial terms such as exchange ratio, implied valuation or expected closing date, but it confirms that:
- The deal is subject to customary conditions, including Core Scientific stockholder approval and required regulatory clearances.
- CoreWeave will register the shares it issues on Form S-4; Core Scientific will distribute a proxy statement/prospectus to its shareholders.
- Both companies caution that forward-looking statements are subject to numerous risks, including integration challenges, regulatory delays, market volatility in AI, power, data-center and crypto-mining sectors, and potential litigation.
The company highlights multiple avenues for obtaining additional information—SEC EDGAR, both companies� IR websites—and reiterates that no offer or solicitation is being made by this communication. Exhibit 104 provides iXBRL cover-page data.
Investment perspective: A proposed all-stock acquisition is typically neutral-to-positive for the target’s equity holders because it can crystallize strategic value and provide ownership in a larger combined entity, but the absence of pricing, conversion ratio and timeline leaves material uncertainty. Shareholders should monitor subsequent S-4 filings for definitive terms.